These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 17941333)
1. Screening life insurance applicants with hemoglobin A1c: a pilot study of cost-benefit. Hale CS J Insur Med; 2007; 39(2):89-97. PubMed ID: 17941333 [TBL] [Abstract][Full Text] [Related]
2. Screening life insurance applicants with hemoglobin A1c. Rogers GP J Insur Med; 2008; 40(1):83. PubMed ID: 18924372 [No Abstract] [Full Text] [Related]
3. [Usefulness of hemoglobin A1c and fructosamine for screening of glucose intolerance in community adults]. Amano H; Shibata H; Haga H; Kumagai S; Suzuki T; Nagai H; Yasumura S Nihon Ronen Igakkai Zasshi; 1994 Feb; 31(2):116-21. PubMed ID: 8022093 [TBL] [Abstract][Full Text] [Related]
5. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291 [TBL] [Abstract][Full Text] [Related]
6. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants. Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L J Insur Med; 2007; 39(3):174-81. PubMed ID: 18251376 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance. Olson BP; Matter NI; Ediger MN; Hull EL; Maynard JD J Diabetes Sci Technol; 2013 Jul; 7(4):990-1000. PubMed ID: 23911181 [TBL] [Abstract][Full Text] [Related]
8. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Parekh D; Sarathi V; Shivane VK; Bandgar TR; Menon PS; Shah NS Endocr Pract; 2010; 16(4):600-8. PubMed ID: 20350923 [TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of alternative indicators for screening for diabetes mellitus. Shirasaya K; Miyakawa M; Yoshida K; Takahashi E; Shimada N; Kondo T Prev Med; 1999 Aug; 29(2):79-86. PubMed ID: 10446032 [TBL] [Abstract][Full Text] [Related]
10. Screening life insurance applicants for hemoglobin A1c: concerns about standardization and genetic variants. Warber KD; Roberts BD J Insur Med; 2009; 41(1):86. PubMed ID: 19518011 [No Abstract] [Full Text] [Related]
11. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities]. GoĊembiewska E Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752 [TBL] [Abstract][Full Text] [Related]
12. [Screening for type 2 diabetes and impaired glucose tolerance]. Hirata A; Tominaga M Nihon Rinsho; 2005 Feb; 63 Suppl 2():366-71. PubMed ID: 15779405 [No Abstract] [Full Text] [Related]
13. Simple and non-invasive screening method for diabetes based on myoinositol levels in urine samples collected at home. Takakado M; Takata Y; Yamagata F; Yaguchi M; Hiasa G; Sato S; Funada JI; Kawazu S; Osawa H BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049641 [TBL] [Abstract][Full Text] [Related]
14. Role of A1c in the postpartum screening of women with gestational diabetes. Benaiges D; Chillaron JJ; Pedro-Botet J; Mas A; Puig de Dou J; Sagarra E; Carrera MJ; Goday A; Flores-Le Roux JA Gynecol Endocrinol; 2013 Jul; 29(7):687-90. PubMed ID: 23638620 [TBL] [Abstract][Full Text] [Related]
15. The Role of Haemoglobin A1c in Screening Obese Children and Adolescents for Glucose Intolerance and Type 2 Diabetes. Galhardo J; Shield J Acta Med Port; 2015; 28(3):307-15. PubMed ID: 26421782 [TBL] [Abstract][Full Text] [Related]
16. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Fong A; Serra AE; Gabby L; Wing DA; Berkowitz KM Am J Obstet Gynecol; 2014 Dec; 211(6):641.e1-7. PubMed ID: 24912095 [TBL] [Abstract][Full Text] [Related]
17. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard? Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404 [TBL] [Abstract][Full Text] [Related]
19. The association between glycated hemoglobin levels and mortality in non-diabetic elderly subjects. Grossman A; Beloosesky Y; Schlesinger A; Gafter-Gvili A; Koren-Morag N; Meyerovitch J; Weiss A Eur J Intern Med; 2016 Jan; 27():57-61. PubMed ID: 26520045 [TBL] [Abstract][Full Text] [Related]
20. A comparison of home glucose monitoring with determinations of hemoglobin A1c, total glycated hemoglobin, fructosamine, and random serum glucose in diabetic patients. Gebhart SS; Wheaton RN; Mullins RE; Austin GE Arch Intern Med; 1991 Jun; 151(6):1133-7. PubMed ID: 2043015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]